BDX Q3 2025 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.5B+10.4% YoY

Gross Profit

$2.6B47.8% margin

Operating Income

$882M16.0% margin

Net Income

$574M10.4% margin

EPS (Diluted)

$2.00

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$1.0B

Stock-Based Comp.

-$239M

Balance Sheet

Total Assets

$54.9B

Total Liabilities

$29.4B

Stockholders' Equity

$25.5B

Cash & Equivalents

$735M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.5B	$5.0B	+10.4%
Gross Profit	$2.6B	$2.3B	+14.2%
Operating Income	$882M	$602M	+46.5%
Net Income	$574M	$487M	+17.9%

Revenue Segments

Medical

$2.9B53%

Interventional

$1.3B24%

Life Sciences

$1.3B23%

Geographic Segments

UNITED STATES

$3.2B58%

Non-US

$2.3B42%